{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal DB-001",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "The number of days from the first study treatment until return of oxygenation saturation (SpO2) \u2265 93% on room air (or PaO2/FiO2 \u2265 300 mmHg). If patient has chronic lung disease, recovery is defined as pre-COVID-19 SpO2 and O2 support.",
                              "Safety Endpoint",
                              "Efficacy Endpoint"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Time to Recovery",
                              "Incidence of Serious Adverse Events (SAE)",
                              "Number of Patients with All-cause Mortality"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "61 days",
                              "61 days",
                              "61 days"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Direct Biologics, LLC"
                        ],
                        "SeeAlsoLinkURL": [
                              "https://directbiologics.com/"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04493242"
                        ]
                  }
            ]
      }
}